Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$684K Hold
5,325
0.5% 51
2026
Q1
$641K Hold
5,325
0.47% 53
2025
Q4
$561K Hold
5,325
0.44% 54
2025
Q3
$447K Hold
5,325
0.35% 58
2025
Q2
$422K Hold
5,325
0.39% 59
2025
Q1
$478K Hold
5,325
0.48% 49
2024
Q4
$530K Buy
+5,325
New +$549K 0.52% 47

Other funds holding MRK

Rahlfs Capital's MRK Position: Q2 2026 in Review

Rahlfs Capital held its Merck (MRK) position steady in Q2 2026 at 5,325 shares worth $684K. The position accounts for 0.5% of the portfolio, ranked #51.

Rahlfs Capital first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Rahlfs Capital held 5,325 shares of Merck worth $684K as of Q2 2026.
  • Rahlfs Capital left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.5% of Rahlfs Capital's portfolio in Q2 2026, its #51 holding.
  • Rahlfs Capital first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rahlfs Capital's 13F filing for Q2 2026, filed 28 Jul 2026.